Baillie Gifford & Co’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.49K Sell
5
-1
-17% -$324 ﹤0.01% 269
2025
Q4
$1.82K Sell
6
-2
-25% -$655 ﹤0.01% 264
2025
Q3
$2.73K Buy
+8
New +$2.43K ﹤0.01% 263
2025
Q2
Sell
-3,630,710
Closed -$988M 284
2025
Q1
$988M Sell
3,630,710
-40,485
-1% -$9.46M 0.86% 25
2024
Q4
$678M Sell
3,671,195
-34,561
-0.9% -$7.06M 0.52% 41
2024
Q3
$832M Buy
3,705,756
+23,807
+0.6% +$4.28M 0.62% 38
2024
Q2
$525M Sell
3,681,949
-46,781
-1% -$7.21M 0.41% 52
2024
Q1
$583M Sell
3,728,730
-137,719
-4% -$22.2M 0.45% 49
2023
Q4
$697M Sell
3,866,449
-5,149
-0.1% -$931K 0.55% 47
2023
Q3
$696M Buy
3,871,598
+588,294
+18% +$116M 0.64% 42
2023
Q2
$585M Sell
3,283,304
-34,058
-1% -$7.84M 0.5% 48
2023
Q1
$715M Sell
3,317,362
-91,357
-3% -$21.9M 0.65% 36
2022
Q4
$750M Buy
3,408,719
+198,778
+6% +$36.5M 0.78% 33
2022
Q3
$433M Sell
3,209,941
-24,990
-0.8% -$4.29M 0.45% 59
2022
Q2
$524M Sell
3,234,931
-868,037
-21% -$136M 0.54% 51
2022
Q1
$774M Sell
4,102,968
-20,931
-0.5% -$4.45M 0.54% 51
2021
Q4
$1.12B Sell
4,123,899
-125,153
-3% -$42.3M 0.61% 45
2021
Q3
$1.54B Sell
4,249,052
-23,126
-0.5% -$7.56M 0.81% 30
2021
Q2
$1.47B Sell
4,272,178
-156,537
-4% -$51.8M 0.71% 36
2021
Q1
$1.54B Buy
4,428,715
+180,888
+4% +$59.9M 0.86% 30
2020
Q4
$1.1B Buy
4,247,827
+2,812,638
+196% +$774M 0.61% 38
2020
Q3
$411M Buy
1,435,189
+1,109,006
+340% +$261M 0.28% 68
2020
Q2
$61.5M Buy
326,183
+24,160
+8% +$3.93M 0.05% 124
2020
Q1
$37.2M Buy
302,023
+13,348
+5% +$2.09M 0.04% 121
2019
Q4
$47.9M Sell
288,675
-200,219
-41% -$33.3M 0.05% 126
2019
Q3
$59.9M Buy
488,894
+390,370
+396% +$51.9M 0.07% 116
2019
Q2
$12.2M Buy
98,524
+2,950
+3% +$374K 0.01% 184
2019
Q1
$12.6M Buy
95,574
+858
+0.9% +$116K 0.01% 182
2018
Q4
$13.3M Buy
94,716
+12,938
+16% +$1.72M 0.02% 173
2018
Q3
$14.1M Sell
81,778
-1,641
-2% -$276K 0.02% 177
2018
Q2
$12.8M Sell
83,419
-3,998
-5% -$713K 0.01% 168
2018
Q1
$14.7M Buy
87,417
+166
+0.2% +$22.5K 0.02% 158
2017
Q4
$8.53M Buy
87,251
+7,241
+9% +$663K 0.01% 174
2017
Q3
$8.28M Buy
80,010
+5,586
+8% +$416K 0.01% 170
2017
Q2
$3.35M Buy
74,424
+3,559
+5% +$140K ﹤0.01% 187
2017
Q1
$2.59M Buy
70,865
+1,581
+2% +$57.6K ﹤0.01% 184
2016
Q4
$2.1M Buy
69,284
+449
+0.7% +$14.1K ﹤0.01% 192
2016
Q3
$2.12M Buy
68,835
+635
+0.9% +$18.4K ﹤0.01% 191
2016
Q2
$2.03M Buy
68,200
+66,350
+3,586% +$1.95M ﹤0.01% 186
2016
Q1
$54K Buy
+1,850
New +$52.4K ﹤0.01% 196

Other funds holding ONC